Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1325
https://www.valueinhealthjournal.com/article/S1098-3015(16)32691-2/fulltext
Title :
Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32691-2&doi=10.1016/j.jval.2016.09.1325
First page :
A576
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1245